Tardive dyskinesia is most likely to develop in clients on antipsychotic drugs:
a. when drug doses are increased.
b. within the first three weeks of therapy.
c. when long-term therapy is discontinued.
d. when the client exhibits episodes of depression.
ANS: C
Feedback
A Incorrect: This is not true of tardive dyskinesia.
B Incorrect: This is not true of tardive dyskinesia.
C Correct: This is characteristic of the occurrence of tardive dyskinesia.
D Incorrect: This is not true of tardive dyskinesia.
You might also like to view...
The primary focus of your interventions for a 6-year-old child who sleepwalks would be to:
a. Maintain patient safety during episodes of somnambulation. b. Administer and teach about medications to suppress stage III sleep. c. Encourage the child to verbalize feelings regarding sleep pattern. d. Provide a quiet environment for nighttime sleep.
The nurse teaches a patient with hypertension that his well-being will be focused on his ability to:
1. eat the correct diet. 2. manage symptoms. 3. take exercise. 4. adhere to a medication protocol.
he nurse is assessing a patient admitted with acute abdominal pain. Which information would the nurse associate with changes in the gastrointestinal system?
1. The patient is taking more of the proton pump inhibitor than is typically indicated for gastroesophageal reflux. 2. The patient reports that his mother was just diagnosed with renal failure. 3. The patient reports an itchy red rash over his thigh that has been present for several weeks. 4. The patient works as an insurance agent. 5. The patient often repeats himself and seems confused at times.
A nurse is administering pain medication to an 80-year-old man. What altered drug response might be expected due to the patient's age?
A) Decreased gastric pH causing stomach irritation B) Increased possibility of drug toxicity due to increased distribution of water-soluble drugs C) Increased excretion of drugs, leading to possible increased serum levels/toxicity D) Increased possibility of drug toxicity due to higher drug plasma concentrations